Acadia Pharmaceuticals Inc (ACAD)

Investing Cash Flow

-$11.19M

TTM · Period ending: · USD

ACAD logo

ACAD Investing Cash Flow

Latest reported-$11.19M
ACAD TTM Cash from Investing (-$7.38M → -$11.19M)
High-resolution chart · PNG

ACAD investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Acadia Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-11,188,000
-112,234,000
-302,564,000
-124,545,000
-127,650,000
-140,548,000
-30,538,000
-153,035,000
-36,468,000
-174,559,000
31,998,000
14,597,000
-4,072,000
134,414,000
73,241,000
162,538,000
-9,224,000
29,366,000
-71,102,000
-259,609,000
49,706,000
193,778,000
192,509,000
100,323,000
-42,748,000
-158,986,000
-165,836,000
-145,641,000
-123,780,000
-138,349,000
-71,489,000
99,367,000
86,915,000
129,156,000
92,473,000
179,706,000
5,466,000
-40,293,000
-261,924,000
-274,339,000
-111,123,000
-59,599,000
147,570,000
131,321,000
161,886,000
50,312,000
-87,273,000
-118,208,000
-161,024,000
-192,130,000
-126,104,000
-170,699,000
-169,500,000
-62,491,000
-25,528,000
13,341,000
20,563,000
18,592,000
5,980,000
-5,596,000
-7,131,000
-16,314,000
-1,060,000
15,229,000
22,817,000
4,773,000
9,444,000
12,450,000
20,088,000
56,269,000
69,714,000
65,354,000
44,167,000
-37,238,000
-41,902,000
-48,109,000
-45,619,000
-3,569,000
-22,936,000
-17,953,100
-3,992,800
-3,139,600
-6,651,400
-2,993,300
-13,335,900
-13,036,800
-7,378,700
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.